Edwards Can't Get 'Springboard' Damages From Meril At UPC
The Unified Patent Court has ruled that Edwards Lifesciences cannot pursue "springboard" damages reflecting the lasting commercial advantage that Meril may have gained by selling infringing heart valves in Europe....To view the full article, register now.
Already a subscriber? Click here to view full article